Hyperhomocyst(e)inemia as a risk factor after renal transplantation.
Cardiovascular disease (CVD) is one of the leading cause of mortality in renal transplant recipients. Authors review accepted CVD risk factors. The role of additional factors like increased homocysteine level is discussed.
Ducloux
D
D
Department of Nephrology and Renal Transplantation, St Jacques Hospital, Besançon, France.
Motte
G
G
Massy
Z A
ZA
D002318:Cardiovascular Diseases / Q000209:etiology; D005492:Folic Acid / Q000627:therapeutic use; D006397:Hematinics / Q000627:therapeutic use; D006710:Homocysteine / Q000378:metabolism; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications* / Q000188:drug therapy / Q000209:etiology*; D016030:Kidney Transplantation / Q000009:adverse effects*; D012307:Risk Factors
D006397:Hematinics; D006710:Homocysteine; D005492:Folic Acid